Part of a class of medications called GLP-1 receptor agonists, Semaglutide increases insulin secretion, which is good for diabetics. But in higher deses, it acts on centers in the brain and suppresses appetite.

Approved in 2021 by the FDA for chronic weight management in obese/overweight adults, this injection has been descried as a “game changer.”

The most common side effects may include nausea, diarrhea, dizziness, bloating, gas, and heartburn. More serious side effects may include:

-Pancreatitis (inflammation of pancreas)

-Gallbladder problems

-Kidney problems/failure

-Serious allergic reactions

-increased heart rate

-Depression

Semagultide is injected once weekly subcutaneous, and can be done at home or in office. Dosing strength depends on many factors and ultimately your healthcare provider makes the decision.